PARTEX.AI Acquires Strut Health to Gain Direct Access to the U.S. Patient Market and Accelerate AI-Powered Healthcare Innovation

PARTEX.AI Acquires Strut Health to Gain Direct Access to the U.S. Patient Market and Accelerate AI-Powered Healthcare Innovation

Acquisition provides direct patient access and a scalable U.S. healthcare platform to

accelerate AI-enabled healthcare innovation and improve patient outcomes

FRANKFURT / DALLAS – 9 July, 2026 – PARTEX.AI today announced the acquisition of Strut Health, a rapidly growing U.S.-based digital healthcare platform, marking a significant strategic milestone in the company’s evolution toward becoming a leading AI-powered healthcare enterprise.

The acquisition provides PARTEX.AI with immediate access to the U.S. healthcare market, an established digital healthcare infrastructure, direct patient engagement capabilities, and a scalable platform through which the company intends to deploy its proprietary artificial intelligence technologies.

Strut Health has built a successful telehealth platform serving patients across multiple high-growth healthcare categories through a seamless digital experience connecting patients with licensed healthcare professionals and personalized treatment programs. The platform provides PARTEX.AI with something increasingly difficult to build organically: established patient relationships, healthcare delivery capabilities, and operational scale in the world's largest healthcare market.

Unlike traditional technology acquisitions, the transaction is designed to create value through the application of PARTEX.AI’s advanced artificial intelligence capabilities to an existing healthcare business with real-world patient interactions and established market access.

By integrating AI into patient engagement, treatment personalization, clinical workflows, operational processes, and healthcare decision-making, PARTEX.AI aims to unlock new opportunities for growth, efficiency, and improved patient outcomes.

“This acquisition represents a transformational step in the evolution of PARTEX.AI,” said Dr. Gunjan Bhardwaj, CEO of PARTEX.AI. “Strut Health provides us with something that is increasingly difficult to build organically: an operational healthcare platform, patient relationships, and a strong position in the U.S. market. Combined with PARTEX.AI’s proprietary AI capabilities, this creates a powerful foundation for long-term growth and innovation.”

Dr. Bhardwaj added: “We see significant opportunities to introduce AI across the patient journey. Through Strut Health, we have acquired an established healthcare platform and direct access to the U.S. market. Our next step is to leverage PARTEX.AI’s technology and expertise to create a smarter, more personalized, and more efficient healthcare experience.”

The transaction positions PARTEX.AI at the convergence of artificial intelligence, digital health, and healthcare delivery. By combining advanced AI technologies with direct market access, the company believes it is creating a differentiated platform capable of generating proprietary healthcare insights, accelerating innovation, and supporting sustainable long-term value creation.

As healthcare enters a new era driven by artificial intelligence, PARTEX.AI is building the foundation for a next-generation healthcare platform where AI is deployed not only to generate insights, but also to improve how healthcare is delivered, experienced, and scaled.

About PARTEX.AI

PARTEX.AI is a global artificial intelligence company focused on transforming healthcare through advanced AI technologies, proprietary data intelligence, and next-generation healthcare solutions.

About Strut Health

Strut Health is a U.S.-based digital healthcare platform that provides patients with convenient access to licensed healthcare professionals, personalized treatment plans, and prescription therapies through a fully digital experience.